Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH)
Por um escritor misterioso
Descrição
US9701672B2 - Dihydropyridinone MGAT2 inhibitors for use in the
Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the
Emerging novel targets for nonalcoholic fatty liver disease
Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the
Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the
Beyond triglyceride synthesis: the dynamic functional roles of
Beyond triglyceride synthesis: the dynamic functional roles of
Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2
TP-020 (MGAT2-IN-1), MGAT2 Inhibitor
PDF) The Discovery and Pharmacology of a Novel Class of
Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2
Lipid metabolic flux analysis of compA in intestinal mucosa
Full article: Patent landscape for discovery of promising
